AR and posterior cortical atrophy: ADT is the standard indication for treating locally advanced and metastatic PCa, achieved primarily by GnRH (gonadotropin-releasing hormone) agonists (26, 27), GnRH antagonists (28, 29), and androgen receptor antagonistic agents (30).